Generation Lab Secures $11M in Seed Funding Led by Accel to Pioneer Epigenetic Longevity Testing
Longevity startup Generation Lab has raised $11 million in seed funding led by Accel, marking the venture firm’s first investment in the longevity space. The company offers epigenetic testing that analyzes 460 biomarkers across 19 organs to provide personalized aging insights.
Venture Capital Backs Longevity Innovation
Generation Lab, a startup focused on personalized epigenetic testing, has reportedly raised $11 million in seed funding according to sources familiar with the matter. The round was led by Silicon Valley venture firm Accel, representing their first investment in the longevity sector, with participation from Samsung Next and several celebrity-backed investment vehicles.